Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study

Women with hormone-dependent breast cancer are treated with aromatase inhibitors (AI) to slow disease progression by decreasing estrogen levels. However, AI have adverse effects, including pain, with potentially serious impact on quality of life (QOL) and treatment compliance. We evaluated quality o...

Descripción completa

Detalles Bibliográficos
Autores principales: Laroche, Françoise, Perrot, Serge, Medkour, Terkia, Cottu, Paul-Henri, Pierga, Jean-Yves, Lotz, Jean-Pierre, Beerblock, Karine, Tournigand, Christophe, Chauvenet, Laure, Bouhassira, Didier, Coste, Joël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678681/
https://www.ncbi.nlm.nih.gov/pubmed/29117210
http://dx.doi.org/10.1371/journal.pone.0187165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678681/
https://www.ncbi.nlm.nih.gov/pubmed/29117210
http://dx.doi.org/10.1371/journal.pone.0187165

Ejemplares similares